Emergence of Medetomidine in the Illicit Drug Supply: Implications for Emergency Care and Withdrawal Management.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 41575403.
- Also identified by DOI 10.1016/j.annemergmed.2025.12.004.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The US illicit drug supply continues to evolve with increasingly dangerous adulterants, with medetomidine a new agent seen in acute care and other practice settings. We reviewed available literature on illicit drug adulterants, medetomidine intoxication, and sequelae. Although little is known about withdrawal and the clinical manifestations are stark, we reviewed the best available literature on dexmedetomidine withdrawal and suggest approaches for treatment.